SNTI vs ZION · rev $33.0K vs P/E 11, rev $354.0M
Senti Biosciences Inc (SNTI) versus Zions Bancorporation (ZION) — a side-by-side from cached financials, not a winner call.
Senti Biosciences Inc (SNTI) is a biotechnology company listed on NASDAQ.
Zions Bancorporation (ZION) is a banks - regional company listed on US.
Latest reported SNTI revenue for 2026-06-30 was $33.0K. Net income was -$17.0M. SNTI currently screens at market cap $29.6M.
Latest reported ZION revenue for 2026-06-30 was $354.0M. Net income was $686.0M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
SNTI currently screens at market cap $29.6M. ZION currently screens at market cap $8.19B and trailing P/E 10.8.
Not investment advice. Open the SNTI and ZION stock pages for the full models.
Not investment advice.